PDL BioPharma, Inc. (PDLI)
$6.74
0.04 (+0.60%)
| CAPS Rating |
|
|---|---|
| Open | $6.77 |
| Previous Close | $6.70 |
| Daily Range | $6.56 - $6.87 |
| 52-Week Range | $5.20 - $9.92 |
| Market Cap | $806.58M |
| P/E Ratio | 4.32 |
| Dividend (Yield) | 1.00 (11.90%) |
| Volume | 624,544 |
| Average Daily Volume | 3,239,000 |
PDLI
VS S&P 500 (SPY)
How do you think PDLI will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PDLI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PDLI News and Commentary
- CNBC on PDL Biopharma, Inc. – Ockham-RazorWire
- Takeover Likely? Management Says No! – The Motley Fool
- 5 Magical Stocks – The Motley Fool
- 2 Stocks Hitting High Notes – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- 5 Stocks Ready for Liftoff – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- Don't Make a Million-Dollar Mistake – The Motley Fool
- PDL BioPharma's Partnership Makes Sense – The Motley Fool
- Health-Care Stocks the All-Stars Prescribe – The Motley Fool
- When Breaking Up Isn't Hard to Do – The Motley Fool
- An ImClone Deal Will Get Done – The Motley Fool
- Seattle Genetics Has What Others Want – The Motley Fool
- Live From Bio: Activist Investors – The Motley Fool
- PDL Shakeup Lifts Shares – The Motley Fool
- Icahn Girds for Biogen Battle – The Motley Fool
- PDL for Sale, Cheap! – The Motley Fool
- Enzon Shareholders Steal the Show – The Motley Fool
- Tomorrow's Monster Stocks? – The Motley Fool
- PDL Delivers a Dividend – The Motley Fool
RSS Headlines
Fool UK
